BTIG Maintains Buy on Medtronic, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 79.5%

Neg 0% Neu 0% Pos 79.5%

BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $91 to $100.

Comments

No comments yet. Be the first!